Stem Cell Assay

Stem Cell Assay

Global Stem Cell Assays Market to Reach $4.1 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Stem Cell Assays estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$4.1 Billion by 2027, growing at a CAGR of 17.7% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 18.2% CAGR and reach US$3.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 17.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $380.1 Million, While China is Forecast to Grow at 16.7% CAGR

The Stem Cell Assays market in the U.S. is estimated at US$380.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$704.3 Million by the year 2027 trailing a CAGR of 16.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.2% and 15.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Services Segment to Record 13.8% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 13.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$114.7 Million in the year 2020 will reach a projected size of US$280.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 44 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Biolabs, Inc.
  • Cellular Dynamics International
  • GE Healthcare
  • HemoGenix, Inc.
  • Merck & Co., Inc.
  • Miltenyi Biotec GmbH
  • PerkinElmer, Inc.
  • Promega Corporation
  • Stemcell Technologies Canada, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Stem Cell Assay – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Stem Cell Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World 7-Year Perspective for Stem Cell Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
TABLE 3: World Recent Past, Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 4: World 7-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 5: World Recent Past, Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 6: World 7-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World 7-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 9: World Recent Past, Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 10: World 7-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 11: World Recent Past, Current & Future Analysis for Viability/Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 12: World 7-Year Perspective for Viability/Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World 7-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 15: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 16: World 7-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 17: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 18: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World 7-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 21: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 22: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 23: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 24: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 27: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 28: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 30: World 7-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
TABLE 33: World Stem Cell Assay Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 34: USA Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: USA 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 36: USA Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 37: USA 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 38: USA Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 39: USA 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 40: USA Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: USA 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
CANADA
TABLE 42: Canada Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 43: Canada 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 44: Canada Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 45: Canada 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 46: Canada Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Canada 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 48: Canada Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 49: Canada 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
JAPAN
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 50: Japan Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 51: Japan 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 52: Japan Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 54: Japan Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 55: Japan 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 56: Japan Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 57: Japan 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
CHINA
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 58: China Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 60: China Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 61: China 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 62: China Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 63: China 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 64: China Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: China 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
EUROPE
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 66: Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 67: Europe 7-Year Perspective for Stem Cell Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027
TABLE 68: Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 69: Europe 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 70: Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 72: Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 73: Europe 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 74: Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 75: Europe 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
FRANCE
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 76: France Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 78: France Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 79: France 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 80: France Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 81: France 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 82: France Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: France 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
GERMANY
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 84: Germany Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 85: Germany 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 86: Germany Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 87: Germany 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 88: Germany Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 90: Germany Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 91: Germany 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
ITALY
TABLE 92: Italy Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 93: Italy 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 94: Italy Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 96: Italy Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 97: Italy 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 98: Italy Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 99: Italy 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
UNITED KINGDOM
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 100: UK Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: UK 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 102: UK Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 103: UK 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 104: UK Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 105: UK 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 106: UK Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: UK 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
REST OF EUROPE
TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 109: Rest of Europe 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 111: Rest of Europe 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Rest of Europe 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 115: Rest of Europe 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
ASIA-PACIFIC
Stem Cell Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 117: Asia-Pacific 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Asia-Pacific 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 121: Asia-Pacific 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 123: Asia-Pacific 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
REST OF WORLD
TABLE 124: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Rest of World 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2021 & 2027
TABLE 126: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 127: Rest of World 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2021 & 2027
TABLE 128: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 129: Rest of World 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2021 & 2027
TABLE 130: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of World 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings